TLR4 and atherosclerosis: Additionally, it has been reported that plasma levels of circulating TLR4-responsive miRNAs including miR-31, miR-181a, miR-16, and miR-145 were decreased in CAD patients, which may suggest their involvement in the pathogenesis of atherosclerosis.